000			02318 a2200685 4500
005			20250516074301.0
264		0	_c20120202
008			201202s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa1111065 _2doi
040			_aNLM _beng _cNLM
100	1		_avon Minckwitz, Gunter
245	0	0	_aNeoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. _h[electronic resource]
260			_bThe New England journal of medicine _cJan 2012
300			_a299-309 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBevacizumab
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease Progression
650	0	4	_aEpirubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLogistic Models
650	0	4	_aMastectomy, Segmental
650	0	4	_aMedication Adherence
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aReceptor, ErbB-2
700	1		_aEidtmann, Holger
700	1		_aRezai, Mahdi
700	1		_aFasching, Peter A
700	1		_aTesch, Hans
700	1		_aEggemann, Holm
700	1		_aSchrader, Iris
700	1		_aKittel, Kornelia
700	1		_aHanusch, Claus
700	1		_aKreienberg, Rolf
700	1		_aSolbach, Christine
700	1		_aGerber, Bernd
700	1		_aJackisch, Christian
700	1		_aKunz, Georg
700	1		_aBlohmer, Jens-Uwe
700	1		_aHuober, Jens
700	1		_aHauschild, Maik
700	1		_aFehm, Tanja
700	1		_aMüller, Berit Maria
700	1		_aDenkert, Carsten
700	1		_aLoibl, Sibylle
700	1		_aNekljudova, Valentina
700	1		_aUntch, Michael
773	0		_tThe New England journal of medicine _gvol. 366 _gno. 4 _gp. 299-309
856	4	0	_uhttps://doi.org/10.1056/NEJMoa1111065 _zAvailable from publisher's website
999			_c21490795 _d21490795